Meanwhile, the “improved” neuropathy group showed an average increase in TGF-β levels of 5.941 ng/mL (p > 0.05), indicating a trend toward more pronounced changes, even though this was not statistically significant. This evidence concerns the gene TGFB1 and neuropathy.